Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|August 13, 2025
Sterilizing activity of spectinamide MBX-4888A when replacing linezolid in the Nix-TB regimen in the relapsing BALB/c mouse model of tuberculosisNathan Peroutka-Bigus, Michael S Sherman, Firat Kaya, et al.Scientific Reports|April 10, 2020
Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural NetworksBryce C Asay, Blake Blue Edwards, Jenna Andrews, et al.Biorxiv : the Preprint Server for Biology|November 28, 2023
A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled SpectinamidesMalik Zohaib Ali, Taru S Dutt, Amy MacNeill, et al.Antimicrobial Agents and Chemotherapy|September 30, 2025
Sterilizing activity of spectinamide MBX-4888A when replacing linezolid in the Nix-TB regimen in the relapsing BALB/c mouse model of tuberculosisNathan Peroutka-Bigus, Michael S Scherman, Firat Kaya, et al.ACS Infectious Diseases|January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesThulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.Elife|October 8, 2024
A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamidesMalik Zohaib Ali, Taru S Dutt, Amy MacNeill, et al.The Journal of Infectious Diseases|June 4, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of ResistanceAnnamarie E Bustion, Jacqueline P Ernest, Firat Kaya, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2024
Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408Jiuyu Liu, Pradeep B Lukka, Victoria A Ektnitphong, et al.ACS Infectious Diseases|May 30, 2020
Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial ActivityJessica N Akester, Paul Njaria, Aloysius Nchinda, et al.Antimicrobial Agents and Chemotherapy|March 21, 2022
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug TreatmentsChristian Dide-Agossou, Allison A Bauman, Michelle E Ramey, et al.Pageof 8